Brachytherapy for localised prostate cancer

Patterson J
Record ID 32004000034
English
Authors' objectives:

This study aims to assess the effects of brachytherapy versus other radiotherapy, radical prostatectomy, watchful waiting or drug treatments among men with localised prostate cancer.

Authors' recommendations: We found a lack of reliable evidence for effects of brachytherapy in men with localised non-metastatic prostate cancer. Particular difficulties exist in this therapeutic area, since the treatments are still evolving and may be used in many different combinations. Long follow up is required to determine mortality, because of the slow natural history of this disease. We found a large number of small case series, a small number of cohort studies and no randomised controlled trials. Valid comparisons between brachytherapy and other treatments such as watchful waiting, radical prostatectomy, external radiotherapy or anti-androgen drug regimens are not possible based on existing studies. There may be subsets of men who respond better to treatment that includes brachytherapy compared to management without brachytherapy. However, randomised controlled trials with long follow up for clinically important outcomes and adequate description of therapeutic techniques are required to support this conclusion.
Authors' methods: Review
Details
Project Status: Completed
URL for project: http://www.wihrd.soton.ac.uk
Year Published: 2001
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England
MeSH Terms
  • Brachytherapy
  • Prostatic Neoplasms
Contact
Organisation Name: Wessex Institute for Health Research and Development
Contact Address: Pauline King. Wessex Institute for Health Research and Development, Boldrewood Medical School, Bassett Crescent East, Highfield, Southampton. SO16 7PX Tel. +44 1703 595661 Fax +44 1703 595662
Copyright: Bazian Ltd, Wessex Institute for Health Research and Development
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.